Attached files
| file | filename |
|---|---|
| 8-K/A - AMENDMENT TO FORM 8-K - NOVAVAX INC | v377126_8ka.htm |
April 30, 2014
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
| Re: | Novavax, Inc. |
File No. 000-26770
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Novavax, Inc. dated April 30, 2014, and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ GRANT THORNTON LLP